(3S,4S)-3-Amino-1-chloro-4-methylhexan-2-one hydrochloride, 96%, 5g

2,2,2-Trifluoro-1-(pyridin-3-yl)ethane-1,1-diol, 95.0%, 1g

6-(Trifluoromethyl)uracil, 97.0%, 5g

1-(4-Bromomethyl-piperidin-1-yl)-ethanone, 95%, 5g

2-(1-(Tert-butoxycarbonyl)pyrrolidine-2-carboxamido)-[1,1'-biphenyl]-4,4'-dicarboxylic acid, 98%, 500mg

Ethyl 2-(cyclobutylamino)-2-oxoacetate, 98%, 1g

3-Propyl-1H-pyrrolo[2,3-c]pyridin-7(6H)-one, 97.0%, 50mg

((4S)-2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic, 95.0%, 100g

(S)-1-(2-fluoro-3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 97%, 500mg

2-Amino-6,7-dimethoxy-quinoline-3-carboxylic acid amide, 95.0%, 250mg

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 75 mm, 15 m, 1 Piece(s)

Dihydro-1H-cyclopenta[1,2-c:3,4-c']difuran-1,3,4,6(3aH,3bH,6aH)-tetraone, 95.0%, 250mg

3-Bromo-2,2-bis(bromomethyl)propanol, 98.0%, 1kg